- Home
- HSII vs PSNL Comparison
HSII vs PSNL Comparison
Compare HSII & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSII
- PSNL
- Stock Information
- Founded
- HSII 1953
- PSNL 2011
- Country
- HSII United States
- PSNL United States
- Employees
- HSII N/A
- PSNL N/A
- Industry
- HSII Diversified Commercial Services
- PSNL Medical Specialities
- Sector
- HSII Consumer Discretionary
- PSNL Health Care
- Exchange
- HSII Nasdaq
- PSNL Nasdaq
- Market Cap
- HSII 1.0B
- PSNL 854.8M
- IPO Year
- HSII 1999
- PSNL 2019
- Fundamental
- Price
- HSII $58.81
- PSNL $9.87
- Analyst Decision
- HSII Buy
- PSNL Strong Buy
- Analyst Count
- HSII 2
- PSNL 7
- Target Price
- HSII $57.50
- PSNL $10.43
- AVG Volume (30 Days)
- HSII 332.9K
- PSNL 1.6M
- Earning Date
- HSII 11-03-2025
- PSNL 11-04-2025
- Dividend Yield
- HSII 1.02%
- PSNL N/A
- EPS Growth
- HSII N/A
- PSNL N/A
- EPS
- HSII 1.73
- PSNL N/A
- Revenue
- HSII $1,199,854,000.00
- PSNL $69,103,000.00
- Revenue This Year
- HSII $11.42
- PSNL N/A
- Revenue Next Year
- HSII $1.39
- PSNL $29.83
- P/E Ratio
- HSII $34.00
- PSNL N/A
- Revenue Growth
- HSII 11.56
- PSNL N/A
- 52 Week Low
- HSII $36.87
- PSNL $2.83
- 52 Week High
- HSII $58.85
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- HSII 74.31
- PSNL 63.55
- Support Level
- HSII $58.55
- PSNL $7.11
- Resistance Level
- HSII $58.91
- PSNL $9.89
- Average True Range (ATR)
- HSII 0.10
- PSNL 0.88
- MACD
- HSII -0.21
- PSNL 0.13
- Stochastic Oscillator
- HSII 75.00
- PSNL 97.33
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments include the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.